Liyuan Ma

1.5k total citations · 1 hit paper
61 papers, 1.0k citations indexed

About

Liyuan Ma is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Liyuan Ma has authored 61 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 14 papers in Molecular Biology and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Liyuan Ma's work include Blood Pressure and Hypertension Studies (7 papers), Advanced biosensing and bioanalysis techniques (7 papers) and Cardiovascular Health and Risk Factors (6 papers). Liyuan Ma is often cited by papers focused on Blood Pressure and Hypertension Studies (7 papers), Advanced biosensing and bioanalysis techniques (7 papers) and Cardiovascular Health and Risk Factors (6 papers). Liyuan Ma collaborates with scholars based in China, United States and United Kingdom. Liyuan Ma's co-authors include Brian L. VanderBeek, Xiu‐Wei Yang, Lisheng Liu, Dongfeng Gu, Zhe Zheng, Yuejin Yang, Hui‐Jun Li, Shengshou Hu, Runlin Gao and Yongjun Wang and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and American Journal of Public Health.

In The Last Decade

Liyuan Ma

57 papers receiving 1.0k citations

Hit Papers

China cardiovascular diseases report 2018: an updated sum... 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liyuan Ma China 18 269 266 147 108 96 61 1.0k
Jake J. Thiessen Canada 23 234 0.9× 221 0.8× 79 0.5× 177 1.6× 65 0.7× 69 1.6k
Nadereh Rashtchizadeh Iran 23 391 1.5× 63 0.2× 186 1.3× 185 1.7× 51 0.5× 91 1.5k
Lian Wang China 23 390 1.4× 206 0.8× 55 0.4× 301 2.8× 43 0.4× 108 1.7k
Xue Sun China 16 357 1.3× 182 0.7× 64 0.4× 224 2.1× 69 0.7× 33 1.8k
Xiaowen Pan China 11 340 1.3× 124 0.5× 51 0.3× 202 1.9× 74 0.8× 14 1.7k
Hui‐Fang Wang China 22 391 1.5× 83 0.3× 23 0.2× 135 1.3× 35 0.4× 88 1.3k
Seiji Morita Japan 20 306 1.1× 155 0.6× 38 0.3× 305 2.8× 26 0.3× 145 1.5k
Michele Gesualdo Italy 25 232 0.9× 468 1.8× 42 0.3× 238 2.2× 65 0.7× 55 1.7k
Juan Chen China 25 506 1.9× 87 0.3× 35 0.2× 182 1.7× 36 0.4× 95 1.5k

Countries citing papers authored by Liyuan Ma

Since Specialization
Citations

This map shows the geographic impact of Liyuan Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liyuan Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liyuan Ma more than expected).

Fields of papers citing papers by Liyuan Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liyuan Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liyuan Ma. The network helps show where Liyuan Ma may publish in the future.

Co-authorship network of co-authors of Liyuan Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Liyuan Ma. A scholar is included among the top collaborators of Liyuan Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liyuan Ma. Liyuan Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xudong, et al.. (2025). Persistent spectral based machine learning method for autism spectrum disorder classification. Neurocomputing. 651. 130780–130780.
2.
Li, Xiao, Xilang Jin, Liyuan Ma, et al.. (2024). Construction of borate-ester-based COFs with high specific surface area for the detection of H2O content in the food field. Microchemical Journal. 199. 109976–109976. 10 indexed citations
3.
Ma, Liyuan, Xilang Jin, Zhao Cheng, et al.. (2024). Tailored rapid recognizer and adsorbent of ultra-trace Hg2+ with novel benzothiazol-group decorated covalent organic polymers. Journal of Molecular Structure. 1307. 138009–138009.
4.
Zhao, Yanan, Yao Xiao, Liyuan Ma, et al.. (2024). Dual-readout immunoassay based on IFE and p-phenylenediamine for detection of zearalenone. Journal of Food Composition and Analysis. 132. 106311–106311. 1 indexed citations
5.
6.
Yang, Jingang, Yanyan Zhao, Jianyi Wang, et al.. (2024). Current status of emergency medical service use in ST-segment elevation myocardial infarction in China: Findings from China Acute Myocardial Infarction (CAMI) Registry. International Journal of Cardiology. 406. 132040–132040. 2 indexed citations
7.
Gao, Luying, et al.. (2024). The prognostic implication of skip metastasis to lateral neck in patients with papillary thyroid cancer. Quantitative Imaging in Medicine and Surgery. 14(12). 9477–9485. 1 indexed citations
8.
Jin, Xilang, et al.. (2023). Visual detection of water content in liquor with near-infrared fluorescence sensor assisted by smartphone. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 308. 123791–123791. 5 indexed citations
9.
Hunnicutt, Jacob N., et al.. (2023). Real-World Immunosuppressant Treatment Patterns for Patients with Lupus Nephritis in the United States. Rheumatology and Therapy. 10(5). 1305–1318.
10.
Zhang, Xingping, et al.. (2022). Fluorescence determination of glyphosate based on a DNA-templated copper nanoparticle biosensor. Microchimica Acta. 189(4). 158–158. 17 indexed citations
11.
Ma, Liyuan, et al.. (2021). A 10-year retrospective comparative analysis of the clinical features of brucellosis in children and adults. The Journal of Infection in Developing Countries. 15(8). 1147–1154. 11 indexed citations
12.
Ma, Liyuan, et al.. (2018). Interpretation of the report on cardiovascular diseases in China (2017). 23(1). 3–6. 20 indexed citations
13.
Yang, Xiu‐Wei, Liyuan Ma, Qi‐Le Zhou, Wei Xu, & You-Bo Zhang. (2017). SIRT1 activator isolated from artificial gastric juice incubate of total saponins in stems and leaves of Panax ginseng. Bioorganic & Medicinal Chemistry Letters. 28(3). 240–243. 17 indexed citations
14.
Liu, Mingbo, Wen Wang, Liyuan Ma, & Maigeng Zhou. (2015). [Change on burden of diseases from hypercholesterolemia among the Chinese population from 1990 to 2010].. PubMed. 43(9). 802–5. 2 indexed citations
15.
VanderBeek, Brian L., et al.. (2015). The Association between Intravitreal Steroids and Post-Injection Endophthalmitis Rates. Ophthalmology. 122(11). 2311–2315.e1. 66 indexed citations
16.
Ma, Liyuan, Wen Wang, Yong Zhao, et al.. (2012). Combination of Amlodipine plus Angiotensin Receptor Blocker or Diuretics in High-Risk Hypertensive Patients. American Journal of Cardiovascular Drugs. 12(2). 137–142. 15 indexed citations
17.
EauClaire, Steven F., Shuang Cui, Liyuan Ma, et al.. (2012). Mutations in vacuolar H+-ATPase subunits lead to biliary developmental defects in zebrafish. Developmental Biology. 365(2). 434–444. 25 indexed citations
18.
Liu, Li, Wen Wang, Xianmin Meng, et al.. (2010). Left ventricular hypertrophy induced by abdominal aortic banding and its prevention by angiotensin receptor blocker telmisartan—a proteomic analysis. Journal of Physiology and Biochemistry. 66(4). 329–338. 13 indexed citations
19.
Wang, Wen, Liyuan Ma, Mingbo Liu, et al.. (2009). [Effects of amlodipine plus telmisartan or amlodipine plus amiloride regimen on blood pressure control in hypertensive patients: preliminary report of Chinese Hypertension Intervention Efficacy (CHIEF) trial].. PubMed. 37(8). 701–7. 6 indexed citations
20.
He, Hua, Wen Wang, Huimin Zhang, et al.. (2006). Fosinopril and Carvedilol Reverse Hypertrophy and Change the Levels of Protein Kinase Cɛ and Components of its Signaling Complex. Cardiovascular Drugs and Therapy. 20(4). 259–271. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026